All Regulation articles – Page 6
-
NewsWorrisome trend for EU chemical monitoring
Percentage of chemicals non-compliant with Reach in products of ‘unknown’ origin quadrupled between 2019 and 2021
-
NewsExplainer: e-scooter battery fires
In India and across the world, several tragic incidents have prompted scrutiny of small battery vehicles
-
BusinessContaminated cough syrup linked to 66 child deaths in The Gambia
Medicines made by Indian generics firm Maiden Pharmaceuticals have been blamed for acute kidney injuries
-
BusinessAlzheimer’s antibody engenders anticipation
Tantalising press-released data on Biogen and Eisai’s lecanemab prompt questions without firm answers
-
BusinessSilky smooth tissue regeneration
Serigen mediproducts is harnessing one of India’s biggest industries to help heal wounds and rebuild flesh and bone
-
BusinessArrayit chief convicted of fraud over blood testing
Mark Schena misrepresented the company’s value to investors and defrauded public and private insurers
-
BusinessNature-inspired crop protection
Plant extracts, proteins and pheromones aiming to replace conventional chemical pesticides
-
NewsProposal to name PFAS chemicals as ‘hazardous’ alarms industry
EPA’s plan to designate PFOA and PFOS to be hazardous substances could hand chemical companies a clean-up bill for billions of dollars
-
BusinessFatal hydrogen sulfide leak at US waste treatment plant
One worker killed and four others injured at US Ecology site in Ohio
-
NewsWorrying ingredients found in tattoo inks made in the US
Azo-containing dyes and nanoparticles discovered in US tattoo inks often aren’t listed on labels
-
BusinessJ&J to phase out talc-based baby powder worldwide
In the face of thousands of lawsuits, firm will switch to cornstarch-based formulations
-
BusinessProtective treatment for Covid-19 makes minimal impact
Limited uptake of antibody combination for vulnerable patients, while demand for antivirals seems to be slowing
-
BusinessUK Reach costs stretch higher for industry
Government assessment suggests deadlines will be delayed and companies will pay billions for compliance data
-
BusinessChemours sues over US PFAS safety limit
Fluoropolymer maker appeals new safety standard for GenX, calling it ‘scientifically unsound’
-
BusinessCalifornia advances plans to make its own insulin
Governor commits $100 million to develop low-cost insulin and build manufacturing facility to strengthen drug’s supply chain
-
BusinessUS reinstates Superfund taxes to clean up 1300 contaminated sites
Levy on 42 chemicals and their derivatives aims to revive neglected cleanup programme
-
OpinionAlzheimer’s, amyloid and abandoned antibodies
Biogen’s aducanumab is stumbling into obscurity. Where does that leave the amyloid hypothesis?
-
NewsUS environment agency announces new safety limits for fluorinated chemicals
Regulator lowers advisory drinking water levels for two best known PFAS by five orders of magnitude
-
NewsQuestion marks over cannabidiol’s safety in food, European agency finds
Food safety body has already received more than 150 applications to add CBD to food products
-
BusinessData reveals disparities in US refinery benzene emissions
Monitoring shows several facilities consistently exceed federal action levels